4 Results for "

QZ2135

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "QZ2135" in MCE Product Catalog:

Cat. No.: HY-170852
Target:  

PROTACs RET Apoptosis

Research Areas:  

Cancer

QZ2135 is a CRBN-recruiting PROTAC degrader targeting RET kinase, with a DC50 of 4.7 nM. QZ2135 induces RET degradation via the ubiquitin-proteasome system, while blocking RET phosphorylation and downstream signaling pathways, thereby inhibiting the proliferation and inducing apoptosis of cancer cells expressing wild-type or mutant RET. QZ2135 is applicable for cancer research .
loading...
    loading...
Cat. No.: HY-W587352
CAS No.: 87462-66-6
Target:  

PROTAC Linkers

Research Areas:  

Others

7-Iodohept-1-yne is a PROTAC Linker that can be used to synthesize PROTAC QZ2135 (HY-170852) .
loading...
    loading...
Cat. No.: HY-170854
Research Areas:  

Cancer

RET Ligand-Linker Conjugate-1 is the conjugate composed of a RET ligand and a linker. RET Ligand-Linker Conjugate-1 can be used for synthesis of QZ2135 (HY-170852) .
loading...
    loading...
Cat. No.: HY-170853
Research Areas:  

Cancer

RET ligand-3 is a ligand targeting RET, which can be used to synthesize the PROTAC QZ2135 (HY-170852). RET ligand-3 inhibits the RET signaling pathway, induces apoptosis in RET-expressing cells, and exhibits in vivo anti-tumor efficacy in xenograft models. RET ligand-3 is applicable for cancer-related research .
loading...
    loading...